These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8052700)

  • 21. Role of glutathione in the intrinsic radioresistance of cell lines from a mouse squamous cell carcinoma.
    Miura M; Sasaki T
    Radiat Res; 1991 May; 126(2):229-36. PubMed ID: 2023994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma-membrane fluidity studies of murine neuroblastoma and malignant melanoma cells under irradiation].
    Busse E; Zimmer G; Kornhuber B
    Strahlenther Onkol; 1992 Jul; 168(7):419-22. PubMed ID: 1496453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of a Chinese hamster ovary cell line resistant to bifunctional nitrogen mustards.
    Robson CN; Alexander J; Harris AL; Hickson ID
    Cancer Res; 1986 Dec; 46(12 Pt 1):6290-4. PubMed ID: 3779647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Cancer Res; 1990 Aug; 50(15):4453-7. PubMed ID: 2369722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular glutathione levels and sensitivity to radiation and antineoplastic agents in human ovarian cancer.
    Ozols RF; Hamilton TC; Young RC
    Prog Clin Biol Res; 1988; 276():287-93. PubMed ID: 3174681
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.
    Batist G; Torres-Garcia S; Demuys JM; Greene D; Lehnert S; Rochon M; Panasci L
    Mol Pharmacol; 1989 Aug; 36(2):224-30. PubMed ID: 2770701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of the development of melphalan resistance in vitro by selenite.
    Caffrey PB; Zhu M; Frenkel GD
    Biol Trace Elem Res; 1998 Dec; 65(3):187-95. PubMed ID: 9892492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-transit melanoma: the role of alkylating-agent resistance in regional therapy.
    Grubbs EG; Abdel-Wahab O; Cheng TY; Abdel-Wahab Z; Peterson B; Pruitt SK; Colvin OM; Friedman HS; Tyler DS
    J Am Coll Surg; 2004 Sep; 199(3):419-27. PubMed ID: 15325612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of glutathione on the induction of chromosome aberrations, delay in cell cycle kinetics and cell cycle regulator proteins in irradiated mouse bone marrow cells.
    Ray S; Chatterjee A
    Int J Radiat Biol; 2007 May; 83(5):347-54. PubMed ID: 17457759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
    Benathan M; Alvero-Jackson H; Mooy AM; Scaletta C; Frenk E
    Melanoma Res; 1992 Dec; 2(5-6):305-14. PubMed ID: 1337997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells.
    Schnelldorfer T; Gansauge S; Gansauge F; Schlosser S; Beger HG; Nussler AK
    Cancer; 2000 Oct; 89(7):1440-7. PubMed ID: 11013356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism.
    Medh RD; Gupta V; Awasthi YC
    Biochem Pharmacol; 1991 Jul; 42(2):439-41. PubMed ID: 1859455
    [No Abstract]   [Full Text] [Related]  

  • 36. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of X-ray cytotoxicity in proliferating and quiescent murine mammary carcinoma cells.
    Wallen CA; Ridinger DN; Dethlefsen LA
    Cancer Res; 1985 Jul; 45(7):3064-9. PubMed ID: 4005844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered oxidative stress responses in nickel-resistant mammalian cells.
    Salnikow K; Gao M; Voitkun V; Huang X; Costa M
    Cancer Res; 1994 Dec; 54(24):6407-12. PubMed ID: 7987835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.